JSA advises B Capital on primary and secondary investment
US$ 200 million investment in PharmEasy
JSA advises B Capital on primary and secondary investment US$ 200 million investment in PharmEasy J Sagar Associates (JSA) Advocates and Solicitors have advised global investment firm B Capital on primary and secondary investment in API Holdings Private Limited, the parent company of PharmEasy. The JSA team comprised Manvinder Singh (lead partner), Anant Mishra (senior associate)...
JSA advises B Capital on primary and secondary investment
US$ 200 million investment in PharmEasy
J Sagar Associates (JSA) Advocates and Solicitors have advised global investment firm B Capital on primary and secondary investment in API Holdings Private Limited, the parent company of PharmEasy. The JSA team comprised Manvinder Singh (lead partner), Anant Mishra (senior associate) and Vishakha Singh (associate).
PharmEasy is a pre-IPO stage company engaged in the business of inter alia wholesale trade of pharmaceuticals, nutraceuticals and FMCG (fast-moving consumer goods) products. It also provides healthcare solutions using technology.
The total amount raised by the company in the primary round was approximately US$ 200 million. PharmEasy intends to use the proceeds of the round for its general corporate purposes and to enlarge its footprint in business and make further investments.
The fundraising was done with regards to the organic and inorganic growth of the company. Other financiers also contributed to the investment.